Copenhagen, 30 March 2016 – Zealand has increased its share capital with nominal DKK 46,613 divided into 46,613 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of employee warrants granted under two of the company's warrant programs as described in the Articles of Association.
The exercise price is DKK 77.00 per share for 16,613 of the new shares and DKK 87.45 per share for 30,000 of the new shares. The total proceeds to Zealand from the capital increase amounts to DKK 3,902,701.00.
The new shares give rights to dividend and other rights from the time of the warrant holder's exercise notice. Each new share carries one vote at Zealand’s general meetings. Zealand only has one class of shares.
The new shares will be listed on Nasdaq Copenhagen after registration of the capital increase with the Danish Business Authority. Following registration of the new shares, the share capital of Zealand will be nominal DKK 24,399,382 divided into 24,399,382 shares with a nominal value of DKK 1 each.
The amendment of Zealand’s Articles of Association entailed by the share capital increase has today been registered with the Danish Business Authority. The new Articles of Association are attached to this announcement and also available on the company’s website: www.zealandpharma.com.
